Tazemetostat is an oral, small-molecule, selective inhibitor of the EZH2 (enhancer of zeste homolog 2) protein that is used to treat certain types of cancer. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma that is not curable by surgery or radiation. Tazemetostat is also being studied as a treatment for other types of cancer such as ovarian cancer, small cell lung cancer, and diffuse large B-cell lymphoma (DLBCL).
Tazemetostat is a medication used to treat specific cancers by targeting their growth process. Here's a breakdown of its key features:
- Type of Drug: EZH2 inhibitor (a type of targeted therapy)
- Uses:
- Epithelioid sarcoma (a rare slow-growing cancer of soft tissue) in adults and children 16 years of age and older, when surgery isn't an option or hasn't been successful.
- Follicular lymphoma (a type of non-Hodgkin lymphoma, a blood cancer) in adults whose cancer has either returned or not responded to at least two other treatments. In some cases, it can be used when no other treatment options are available.
- How it Works: Tazemetostat works by inhibiting an enzyme called EZH2. This enzyme plays a role in regulating gene activity in cancer cells. By blocking EZH2, tazemetostat disrupts the growth and spread of cancer cells.
Benefits:
- Targets a specific pathway in cancer cells, potentially offering a more precise treatment approach compared to traditional chemotherapy.
Important Considerations:
- Tazemetostat is typically used after other treatments haven't been successful.
- It's an oral medication taken in tablet form.
- Like any medication, tazemetostat can cause side effects. Some common ones include fatigue, low blood cell counts (which can increase your risk of infection), loss of appetite, nausea, vomiting, and constipation.
- It's important to talk to your doctor about the potential risks and benefits of tazemetostat before taking it. They can determine if it's the appropriate treatment for your specific type and stage of cancer.
Here are some additional points to note:
- Tazemetostat is still under investigation for use in treating other types of cancer.
- Pregnant or breastfeeding women should not take tazemetostat due to the potential risk of harm to the developing baby.